BrainsWay Ltd. (BWAY)
After hours:
| Previous Close | 5.38 |
| Open | 5.34 |
| Bid | 5.45 x 400 |
| Ask | 5.54 x 100 |
| Day's Range | 5.13 - 5.52 |
| 52 Week Range | 1.49 - 7.61 |
| Volume | |
| Avg. Volume | 85,853 |
| Market Cap | 91.417M |
| Beta (5Y Monthly) | 0.34 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.26 |
| Earnings Date | Aug 07, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.35 |
ZacksWall Street Analysts Believe Brainsway (BWAY) Could Rally 120.45%: Here's is How to Trade
The consensus price target hints at a 120.5% upside potential for Brainsway (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
GlobeNewswireBrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
Generated Significant 37% Year-over-Year Revenue Growth in Q1 2024 Recorded Positive Quarterly Net Income for Second Consecutive Quarter, and Positive Adjusted EBITDA and Cash Flow from Operations for Third Consecutive Quarter Conference Call to be Held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, May 08, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported f
- GlobeNewswire
BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024
BURLINGTON, Mass. and JERUSALEM, April 24, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its first quarter 2024 financial results as well as operational highlights before the open of the U.S. financial markets on Wednesday, May 8, 2024. The Company will host a conference call and webcast at 8:30 AM Eastern Time to dis
